University Briefs

Wbrried that gene-splicers will create killer potatoes or rampaging soybeans? Rest easy, says a new report from the Boyce Thompson Institute for Plant Research at Cornell. The report concludes that field tests of crop plants that have been genetically altered to resist insects or disease pose little risk to the environment. It also chides the government for imposing generous restrictions for the testing and use of gene-spliced plants, but not of new varieties produced by traditional techniques

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Wbrried that gene-splicers will create killer potatoes or rampaging soybeans? Rest easy, says a new report from the Boyce Thompson Institute for Plant Research at Cornell. The report concludes that field tests of crop plants that have been genetically altered to resist insects or disease pose little risk to the environment. It also chides the government for imposing generous restrictions for the testing and use of gene-spliced plants, but not of new varieties produced by traditional techniques. “Regulatory considerations and risk assessment of biotechnology should focus not on how a given crop plant is made, but what new traits it has and where it’s going to be used,” says the report. The notion struck a responsive chord; scientists are now considering whether some plant varieties could be made exempt from parts of the review process altogether, says Daniel Jones, deputy director of the USDA office of Agricultural Biotechnology. Based on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies